Clinical trial NCT03738761 - References

Hypertension — Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine

Citation(s)

•   Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ; HYVET Study Group
  Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008 May 1;358(18):1887-98. doi: 10.1056/NEJMoa0801369. Epub 2008 Mar 31.
•   Capone P, Vukovich RA, Neiss ES, Bolton S, Reeves RL
  Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension. Clin Ther. 1983;5(3):305-16.
•   Chaffman M, Heel RC, Brogden RN, Speight TM, Avery GS
  Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs. 1984 Sep;28(3):189-235.
•   Cohn JN, Julius S, Neutel J, Weber M, Turlapaty P, Shen Y, Dong V, Batchelor A, Guo W, Lagast H
  Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial. Am J Hypertens. 2004 Feb;17(2):134-8.
•   Corea L, Cardoni O, Fogari R, Innocenti P, Porcellati C, Provvidenza M, Meilenbrock S, Sullivan J, Bodin F
  Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine. Clin Pharmacol Ther. 1996 Sep;60(3):341-6.
•   Dahlöf B, Gosse P, Guéret P, Dubourg O, de Simone G, Schmieder R, Karpov Y, García-Puig J, Matos L, De Leeuw PW, Degaute JP, Magometschnigg D; PICXEL Investigators
  Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens. 2005 Nov;23(11):2063-70.
•   Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators
  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005 Sep 10-16;366(9489):895-906.
•   Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM
  Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60.
•   De Divitiis O, Di Somma S, Petitto M, Fazio S, Ligouri V
  Indapamide and atenolol in the treatment of hypertension: double-blind comparative and combination study. Curr Med Res Opin. 1983;8(7):493-500.
•   Degaute JP, Leeman M, Desche P
  Long-term acceptability of perindopril: European multicenter trial on 856 patients. Am J Med. 1992 Apr 27;92(4B):84S-90S.
•   Donnelly R
  Clinical implications of indapamide sustained release 1.5 mg in hypertension. Clin Pharmacokinet. 1999;37 Suppl 1:21-32. Review.
•   Emeriau JP, Knauf H, Pujadas JO, Calvo-Gomez C, Abate G, Leonetti G, Chastang C; European Study Investigators
  A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study. J Hypertens. 2001 Feb;19(2):343-50.
•   Ferrari R
  Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Expert Rev Cardiovasc Ther. 2005 Jan;3(1):15-29. Review.
•   Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003 Sep 6;362(9386):782-8.
•   Frishman WH, Brobyn R, Brown RD, Johnson BF, Reeves RL, Wombolt DG
  Amlodipine versus atenolol in essential hypertension. Am J Cardiol. 1994 Jan 27;73(3):50A-54A.
•   Gosse P
  Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Expert Rev Cardiovasc Ther. 2006 May;4(3):319-33. Review.
•   Guo W, Turlapaty P, Shen Y, Dong V, Batchelor A, Barlow D, Lagast H
  Clinical experience with perindopril in patients nonresponsive to previous antihypertensive therapy: a large US community trial. Am J Ther. 2004 May-Jun;11(3):199-205.
•   Haria M, Wagstaff AJ
  Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs. 1995 Sep;50(3):560-86. Review. Erratum in: Drugs 1995 Nov;50(5):896.
•   Hurst M, Jarvis B
  Perindopril: an updated review of its use in hypertension. Drugs. 2001;61(6):867-96. Review.
•   Jassim Al Khaja KA, Sequeira RP, Mathur VS
  Rational pharmacotherapy of hypertension in the elderly: analysis of the choice and dosage of drugs. J Clin Pharm Ther. 2001 Feb;26(1):33-42.
•   Julius S, Cohn JN, Neutel J, Weber M, Turlapaty P, Shen Y, Dong V, Batchelor A, Lagast H
  Antihypertensive utility of perindopril in a large, general practice-based clinical trial. J Clin Hypertens (Greenwich). 2004 Jan;6(1):10-7.
•   Kubik MM, Coote JH
  Comparison of the antihypertensive effects of indapamide and metoprolol. Postgrad Med J. 1981;57 Suppl 2:44-50.
•   Kuwajima I, Fujisawa A, Mitani K, Suzuki Y, Kuramoto K
  Effect of perindopril on 24-hour blood pressure levels and hemodynamic responses to physical and mental stress in elderly hypertensive patients. Clin Ther. 1994 Nov-Dec;16(6):962-71.
•   Lacourciere Y
  Analysis of well-being and 24-hour blood pressure recording in a comparative study between indapamide and captopril. Am J Med. 1988 Jan 29;84(1B):47-52.
•   Lau CP, Cheung BM
  Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: a randomized double-blind study. J Cardiovasc Pharmacol. 1996 Aug;28(2):328-31.
•   Leenen FH, Tanner J, McNally CF
  Antihypertensive efficacy of the ACE-inhibitor perindopril in the elderly. J Hum Hypertens. 2000 May;14(5):321-5.
•   Lefebvre J, Poirier L, Archambault F, Jewell D, Reed CV, Lacourcière Y
  Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study. Can J Cardiol. 1998 May;14(5):682-8.
•   Lorimer AR, Lyons D, Fowler G, Petrie JC, Rothman MT
  Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressures. J Hum Hypertens. 1998 Jun;12(6):411-6.
•   Lüscher TF, Cosentino F
  The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal. Drugs. 1998 Apr;55(4):509-17. Review.
•   MacFadyen RJ, Lees KR, Reid JL
  Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J. 1991 Sep;66(3):206-11.
•   Macfadyen RJ, Lees KR, Reid JL
  Perindopril. A review of its pharmacokinetics and clinical pharmacology. Drugs. 1990;39 Suppl 1:49-63. Review.
•   Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members
  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
•   Mimran A, Zambrowski JJ, Coppolani T
  Indapamide in hypertension: results of a French multi-centre study in ambulant subjects. Curr Med Res Opin. 1983;8 Suppl 3:105-8.
•   Mogensen CE, Viberti G, Halimi S, Ritz E, Ruilope L, Jermendy G, Widimsky J, Sareli P, Taton J, Rull J, Erdogan G, De Leeuw PW, Ribeiro A, Sanchez R, Mechmeche R, Nolan J, Sirotiakova J, Hamani A, Scheen A, Hess B, Luger A, Thomas SM; Preterax in Albuminuria Regression (PREMIER) Study Group
  Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension. 2003 May;41(5):1063-71. Epub 2003 Mar 24.
•   Morledge JH
  Clinical efficacy and safety of indapamide in essential hypertension. Am Heart J. 1983 Jul;106(1 Pt 2):229-32.
•   Mourad JJ, Waeber B, Zannad F, Laville M, Duru G, Andréjak M; investigators of the STRATHE trial
  Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. J Hypertens. 2004 Dec;22(12):2379-86. Erratum in: J Hypertens. 2007 Jan;25(1):258.
•   Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, et al
  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993 Aug 11;270(6):713-24.
•   O'Loughlin DC, Chu VL, Singh D
  Perindopril. Heart Dis. 2000 Nov-Dec;2(6):446-55. Review.
•   Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J
  Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension. Clin Ther. 1996 Jul-Aug;18(4):608-25.
•   Osterloh I
  The safety of amlodipine. Am Heart J. 1989 Nov;118(5 Pt 2):1114-9; discussion 1119-20.
•   Passeron J, Pauly N, Desprat J
  International multicentre study of indapamide in the treatment of essential arterial hypertension. Postgrad Med J. 1981;57 Suppl 2:57-9.
•   Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B
  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007 Sep 8;370(9590):829-40.
•   Prisant LM; Dilacor XR/Lozol Study Group
  Ambulatory blood pressure profiles in patients treated with once-daily diltiazem extended-release or indapamide alone or in combination. Am J Ther. 2000 May;7(3):177-84.
•   PROGRESS Collaborative Group
  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001 Sep 29;358(9287):1033-41. Erratum in: Lancet 2001 Nov 3;358(9292):1556. Lancet 2002 Jun 15;359(9323):2120.
•   Sami MH
  Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure. Can J Cardiol. 1994 Nov;10 Suppl D:13D-16D. Review.
•   Schmieder RE
  The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm. Clin Exp Hypertens. 2010 Jan;32(1):35-42. doi: 10.3109/10641960902960532. Review.
•   Sonnenblick EH
  Perindopril treatment for congestive heart failure. Am J Cardiol. 2001 Oct 4;88(7A):19i-27i. Review.
•   Speirs C, Wagniart F, Poggi L
  Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients. Br J Clin Pharmacol. 1998 Jul;46(1):63-70.
•   Suraniti S, Berrut G, Marre M, Fressinaud P
  Antihypertensive efficacy and acceptability of perindopril in elderly hypertensive patients. Am J Cardiol. 1993 Jun 24;71(17):28E-31E.
•   Waeber B, Feihl F, Ruilope LM
  Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection. Drugs. 2009;69(13):1761-76. doi: 10.2165/11316710-000000000-00000. Review.
•   Whitworth JA; World Health Organization, International Society of Hypertension Writing Group
  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003 Nov;21(11):1983-92.
•   Zannad F, Bernaud CM, Fay R
  Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group. J Hypertens. 1999 Jan;17(1):137-46.

Fixed-Dose Combination of Perindopril/Amlodipine (Amlessa®) and Fixed-Dose Combination of Perindopril/Indapamide /Amlodipine (Co-Amlessa®) - Contribution to Management in Newly Diagnosed and Uncontrolled Hypertensive Patients

Details for clinical trial NCT03738761